By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Investment bank Canaccord Genuity has cut its price target on Gen-Probe's stock to $75 from $88, saying that there appears to be no competitive bids to acquire the molecular diagnostics firm.
Registering provides access to this and other free content.
Already have an account?Login Now.
Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.
The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.
In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.
The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.